Publication Name	World Journal of Stem Cells
Manuscript ID	6791
Country	United States

Received	2013-10-29 10:09
Peer-Review Started	2013-10-30 10:54
To Make the First Decision	2013-12-25 18:00
Return for Revision	2013-12-30 15:54
Revised	2014-01-14 12:03
Second Decision	2014-03-04 09:59
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-03-04 10:31
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-04-19 15:55
Publish the Manuscript Online	2014-04-28 14:14

ISSN	1948-0210 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Review
Article Title	Progress of mesenchymal stem cell therapy for neural and retinal diseases
Manuscript Source	Invited Manuscript
All Author List	Tsz Kin Ng, Veronica R Fortino, Daniel Pelaez and Herman S Cheung
Funding Agency and Grant Number	Funding Agency Grant Number Veterans Affairs (VA) Merit Review Grant Senior VA Research Career Scientist Award, Miami
Corresponding Author	Herman S Cheung, PhD, Professor, Geriatric Research, Education and Clinical Center, Miami Veterans Affairs Medical Center, 1201 NW 16th Street, Miami, FL 33125, United States. hcheung@med.maimi.edu
Key Words	Mesenchymal stem cells; Stem cell therapy; Central nervous system; Retina; Clinical trial
Core Tip	Central nervous system (CNS) disorders are the most challenging and difficult for functional repair. Neurons are still diminishing in many patients despite surgical and medical interventions. Stem cell therapy has been proposed as a viable option. Mesenchymal stem cell (MSC) is a widely-studied human adult stem cell population. MSCs can be conveniently obtained from different accessible tissues. MSCs have high proliferative and differentiation abilities, providing an inexhaustible source of neurons and glia. MSCs also show neuroprotective effects and possess extraordinary immunomodulatory properties. These qualities heighten the clinical applicability of MSCs when dealing with the pathologies of CNS disorders.
Publish Date	2014-04-28 14:14
Citation	Ng TK, Fortino VR, Pelaez D, Cheung HS. Progress of mesenchymal stem cell therapy for neural and retinal diseases. World J Stem Cells 2014; 6(2): 111-119
URL	http://www.wjgnet.com/1948-0210/full/v6/i2/111.htm
DOI	http://dx.doi.org/10.4252/wjsc.v6.i2.111

Full Article (PDF)	WJSC-6-111.pdf
Full Article (Word)	WJSC-6-111.doc
Manuscript File	6791-Review.docx
Answering Reviewers	6791-Answering reviewers.pdf
Copyright License Agreement	6791-Copyright assignment.pdf
Peer-review Report	6791-Peer review(s).pdf
Scientific Editor Work List	6791-Scientific editor work list.doc